tRF-29-86J8WPMN1EJ3: a tRNA-derived small RNA promoting esophageal cancer progression [0.03%]
促进食管癌发展的tRF-29-86J8WPMN1EJ3小分子遗传物质
Xinnian Yu,Zhipeng Li,Yuqi Fu et al.
Xinnian Yu et al.
Background: Transfer RNA-derived small RNAs (tsRNAs) have been shown to participate in tumorigenesis and progression of human cancers. We aimed to identify dysregulated tsRNAs in esophageal cancer (EC) and uncover the und...
Prognosis and chemotherapy efficacy in small-tumor breast cancer with different immune subtypes: a SEER-based study [0.03%]
基于SEER数据库的不同免疫亚型小肿瘤乳腺癌的预后和化疗疗效研究
Hong Mei Wang,Yue Hui Zhou,Gu Bin Lin et al.
Hong Mei Wang et al.
Background: In the case of lymph node metastasis, small-tumor breast cancer patients show distinct survival rates. Current studies have not conducted in-depth analyses of small-tumor patients with different immune subtype...
Polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) primary prophylaxis significantly reduces the duration of neutropenia in non-Hodgkin's lymphoma patients treated with chemotherapy: a randomised trial (NCT05834751) [0.03%]
聚乙二醇重组人粒细胞刺激因子(Peg-rhG-CSF)一级预防可显著缩短化疗非霍奇金淋巴瘤患者中性粒细胞减少的持续时间：一项随机对照试验(NCT05834751)
Bowen Wang,Luming Cao,Jia Li et al.
Bowen Wang et al.
Background: Neutropenia is one of the most common complications of chemotherapy in lymphoma patients. To treat and prevent this condition, polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating fa...
Targeting MET in advanced and metastatic non-small cell lung cancer: a literature review of the current landscape [0.03%]
晚期和转移性非小细胞肺癌中针对MET的治疗：当前格局文献回顾
Amanda Herrmann,Christopher Grant,Lyudmila Bazhenova
Amanda Herrmann
Background and objective: MET alterations have been identified as both primary oncogenic drivers and drivers of acquired resistance in non-small cell lung cancer (NSCLC). There are several mechanisms by which the MET axis...
Erratum: Neuroepithelial cell transforming 1 as a key regulator in non-small cell lung cancer: unveiling causal links and therapeutic potentials [0.03%]
订正：神经上皮细胞转化1作为非小细胞肺癌的关键调节因子：揭示因果关系和治疗潜力
Editorial Office
Editorial Office
[This corrects the article DOI: 10.21037/tcr-24-587.]. © AME Publishing Company.
Published Erratum
Translational cancer research. 2025 Dec 31;14(12):9099. DOI:10.21037/tcr-2025b-19 2025
Stratifying prognosis in stage III colorectal cancer patients: the role of tumor deposits and lymph node ratio [0.03%]
分层评估III期结直肠癌患者的预后：肿瘤沉积和淋巴结比值的作用
Xiaoqiang Wang,Xufeng Shu,Chendong Yuan et al.
Xiaoqiang Wang et al.
Background: The combined effect of tumor deposition (TD) and positive lymph node ratio (LNR) in colorectal cancer (CRC) is unknown. The aim of this study was to investigate the effects of TD and LNR in the prognosis of po...
Targeted next-generation sequencing reveals genomic differences between male and female breast cancer [0.03%]
靶向下一代测序揭示了乳腺癌男性和女性患者间的基因组差异
Jiyuan Zhu,Shanshan Xu,Wei Hua et al.
Jiyuan Zhu et al.
Background: Compared with female breast cancer (FBC), male breast cancer (MBC) is often detected at the advanced stage and has a poorer prognosis. Due to the limited research data on MBC, its clinical diagnosis and treatm...
The value of different machine learning radiomics based on DCE-MRI in predicting axillary lymph node status of breast cancer [0.03%]
基于DCE-MRI的不同机器学习影像组学在预测乳腺癌腋窝淋巴结状态中的价值评估
Han Wang,Li Gong
Han Wang
Background: The accurate preoperative assessment of axillary lymph node (ALN) status is critical for therapeutic decision-making in primary breast cancer (BC), yet current methods are either invasive or lack precision. Th...
Mechanistic study of LINC01296 mediating TRIP13 regulation of neuroblastoma progression [0.03%]
LINC01296介导TRIP13调控神经母细胞瘤进展的机制研究
Yuanbin He,Jiansen Fan,Yu Lin et al.
Yuanbin He et al.
Background: Neuroblastoma (NB) is an embryonic cancer arising from neural crest cells. Long non-coding RNA (lncRNA) plays an important role in the development of tumors. Several studies have reported that LINC01296 and th...
Successful treatment of lung squamous cell carcinoma with envafolimab, a PD-L1 inhibitor combined with chemotherapy: a case report [0.03%]
恩瓦弗利马联合化疗成功治疗肺鳞癌一例报告
Xin Sun,Yu Tang,Yue Zhu et al.
Xin Sun et al.
Background: Metastatic non-small-cell lung cancer (NSCLC) represents a significant clinical challenge and is the leading cause of cancer-related death worldwide. Immune checkpoint inhibitors (ICIs), particularly those tar...